跳至主要内容
临床试验/IRCT2017080435442N1
IRCT2017080435442N1已完成1 期

A Clinical trial to evaluate the effects of intrapulmonary injection of bone marrow derived mononuclear cells along with pulmonary hypertension drugs on pulmonary pressure in patients with Eisenmenger syndrome

Vice chancellor for research, Shiraz University of Medical Sciences0 个研究点目标入组 5 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • operated VSD (ventricular septal defect) and pulmonary hypertension (Eisenmenger)? not improved pulmunary HTN 2years after surgery (despite recieving routine medical therapy)
  • Exclusion criteria: absence of consent? finding clot in heart? not tolerating catheterism

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Shiraz University of Medical Sciences

相似试验